HYALUTE

Serial Number 90700987
733

Registration Progress

Application Filed
May 10, 2021
Under Examination
Jun 6, 2023
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered

Trademark Image

HYALUTE

Basic Information

Serial Number
90700987
Filing Date
May 10, 2021
Published for Opposition
April 11, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jun 5, 2025
Application
Pending
Classes
005

Rights Holder

Prohibix LLC

16
Address
Bldg. 176
3401 Grays Ferry Avenue
Philadelphia, PA 19146

Ownership History

Prohibix LLC

Original Applicant
16
Philadelphia, PA

Prohibix LLC

Owner at Publication
16
Philadelphia, PA

Legal Representation

Attorney
LAURA S LIPSCHUTZ

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

48 events
Date Code Type Description Documents
Dec 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 5, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 7, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 6, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 6, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 6, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 6, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 6, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 27, 2023 EXPT T EXPARTE APPEAL TERMINATED Loading...
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 7, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 7, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 7, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 7, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 7, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 14, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 14, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 13, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Feb 13, 2023 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Feb 13, 2023 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Feb 13, 2023 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Aug 13, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Aug 13, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 13, 2022 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 23, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 22, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 22, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 22, 2022 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Jan 22, 2022 GPRA F PRIORITY ACTION E-MAILED Loading...
Jan 22, 2022 CPRA R PRIORITY ACTION WRITTEN Loading...
Jan 13, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2021 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Aug 26, 2021 ALIE A ASSIGNED TO LIE Loading...
Jun 11, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Aug 11, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 13, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Therapeutic, anti-inflammatory and filling medical preparations and formulations in the nature of injectable tissue hyaluronic acid for use in medicine, veterinary medicine, medical aesthetics, and women's health

Classification

International Classes
005